Doron Gothelf Selected Research

DiGeorge Syndrome (Syndrome, DiGeorge)

9/2022	Stimulant treatment effectiveness, safety and risk for psychosis in individuals with 22q11.2 deletion syndrome.
1/2022	Blood brain barrier permeability increases with age in individuals with 22q11.2 deletion syndrome.
8/2020	Effectiveness and side effects of psychopharmacotherapy in individuals with 22q11.2 deletion syndrome with comorbid psychiatric disorders: a systematic review.
1/2020	Complete Sequence of the 22q11.2 Allele in 1,053 Subjects with 22q11.2 Deletion Syndrome Reveals Modifiers of Conotruncal Heart Defects.
1/2020	Exploring the potential association among sleep disturbances, cognitive impairments, and immune activation in 22q11.2 deletion syndrome.
11/2017	Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits.
11/2017	Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome.
1/2017	The Effectiveness and Safety of Antipsychotic and Antidepressant Medications in Individuals with 22q11.2 Deletion Syndrome.
5/2015	Copy-Number Variation of the Glucose Transporter Gene SLC2A3 and Congenital Heart Defects in the 22q11.2 Deletion Syndrome.
4/2015	Thymic and bone marrow output in individuals with 22q11.2 deletion syndrome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Doron Gothelf Research Topics

Disease

17	DiGeorge Syndrome (Syndrome, DiGeorge) 09/2022 - 10/2003
10	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 09/2022 - 10/2003
8	Psychotic Disorders (Schizoaffective Disorder) 09/2022 - 01/2008
6	Anxiety Disorders (Anxiety Disorder) 01/2017 - 10/2002
5	Schizophrenia (Dementia Praecox) 01/2019 - 05/2003
4	Weight Gain 01/2021 - 03/2002
3	Mental Disorders (Mental Disorder) 07/2022 - 01/2008
3	Depressive Disorder (Melancholia) 01/2016 - 06/2008
3	Major Depressive Disorder (Major Depressive Disorders) 09/2011 - 12/2005
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2019 - 01/2016
2	Intellectual Disability (Idiocy) 11/2012 - 01/2005
2	Developmental Disabilities (Developmental Disability) 01/2012 - 01/2005
1	Medically Unexplained Symptoms 07/2022
1	Insulin Resistance 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Autistic Disorder (Autism) 01/2020
1	Glycogen Storage Disease Type IIb 09/2017
1	Congenital Heart Defects (Congenital Heart Defect) 05/2015
1	Cognitive Dysfunction 04/2015
1	Nervous System Diseases (Neurological Disorders) 11/2012
1	Microcephaly 11/2012
1	Williams Syndrome (Williams-Beuren Syndrome) 01/2012
1	Somatoform Disorders (Somatoform Disorder) 02/2011
1	Hypochondriasis 02/2011
1	Body Dysmorphic Disorders (Body Dysmorphic Disorder) 02/2011
1	Conversion Disorder (Astasia Abasia) 02/2011
1	Hearing Loss (Hearing Impairment) 02/2011
1	Familial cyclic vomiting syndrome 12/2010
1	Fragile X Syndrome (Martin Bell Syndrome) 01/2008
1	Genetic Predisposition to Disease (Genetic Predisposition) 06/2007
1	Neoplasms (Cancer) 12/2005
1	Hyperglycemia 01/2003
1	Social Phobia 10/2002

Drug/Important Bio-Agent (IBA)

8	Methylphenidate (Ritalin)FDA LinkGeneric 09/2022 - 10/2003
7	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 09/2022 - 11/2005
5	Antipsychotic Agents (Antipsychotics)IBA 11/2020 - 03/2002
4	Biological ProductsIBA 07/2022 - 01/2005
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2005
3	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 01/2008
3	Risperidone (Risperdal Consta)FDA LinkGeneric 11/2020 - 03/2002
3	Pharmaceutical PreparationsIBA 01/2019 - 10/2002
3	Citalopram FDA LinkGeneric 09/2011 - 12/2007
3	Olanzapine (Zyprexa)FDA Link 01/2003 - 03/2002
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 11/2017
2	Indicators and Reagents (Reagents)IBA 11/2017 - 04/2015
2	Antidepressive Agents (Antidepressants)IBA 01/2017 - 01/2016
2	EnzymesIBA 03/2014 - 11/2012
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 07/2022
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2022
1	Insulin (Novolin)FDA Link 01/2021
1	Serotonin AntagonistsIBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2020
1	Escitalopram FDA Link 01/2019
1	Histones (Histone)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2017
1	Interleukin-10 (Interleukin 10)IBA 11/2017
1	Lysosomal Membrane ProteinsIBA 09/2017
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2016
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 01/2016
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 05/2015
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2015
1	Messenger RNA (mRNA)IBA 03/2014
1	3' Untranslated Regions (3' UTR)IBA 03/2014
1	Proteins (Proteins, Gene)FDA Link 03/2014
1	Proline Oxidase (Proline Dehydrogenase)IBA 11/2013
1	prolylarginineIBA 11/2013
1	Eukaryotic Initiation Factor-2 (EIF 2)IBA 11/2012
1	S-Adenosylmethionine (Ademetionine)IBA 11/2012
1	Analgesics (Analgesic Drugs)IBA 02/2011
1	Carbamazepine (Tegretol)FDA LinkGeneric 02/2011
1	BenzodiazepinesIBA 02/2011
1	Fragile X Mental Retardation ProteinIBA 01/2008
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 12/2007
1	Fluvoxamine (Luvox)FDA LinkGeneric 12/2005
1	Dopamine Receptors (Dopamine Receptor)IBA 05/2003
1	Haloperidol (Haldol)FDA LinkGeneric 03/2002

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 11/2020 - 02/2011
2	Psychology Biofeedback (Biofeedback) 02/2011 - 12/2010
1	Electrodes (Electrode) 01/2019
1	Thymectomy 04/2015
1	Hypnosis (Mesmerism) 02/2011